Cost analysis of new robotic competitors: a comparison of direct costs for initial hospital stay between Da Vinci and Hugo RAS for radical prostatectomy.
Cost analysis
Direct costs
Economics
New robotic systems
Robotic surgery
Journal
Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401
Informations de publication
Date de publication:
13 Jun 2024
13 Jun 2024
Historique:
received:
16
02
2024
accepted:
24
03
2024
medline:
13
6
2024
pubmed:
13
6
2024
entrez:
13
6
2024
Statut:
epublish
Résumé
Robotic surgery with Da Vinci has revolutionized the treatment of several diseases, including prostate cancer; nevertheless, costs remain the major drawback. Recently, new robotic platforms entered the market aiming to reduce costs and improve the access to robotic surgery. The aim of the study is to compare direct cost for initial hospital stay of radical prostatectomy performed with two different robotic systems, the Da Vinci and the new Hugo RAS system. This is a projection study that applies cost of robotic surgery, derived from a local tender, to the clinical course of robotic radical prostatectomy (RALP) performed with Da Vinci and Hugo RAS. The study was performed in a public referral center for robotic surgery equipped with both systems. The cost of robotic surgery from a local tender were considered and included rent, annual maintenance, and a per-procedure fee covering the setup of four robotic instruments. Those costs were applied to patients who underwent RALP with both systems since November 2022. The primary endpoint is to evaluate direct costs of initial hospital stay for Da Vinci and Hugo RAS, by considering equipment costs (as derived from the tender), and costs of theater and of hospitalization. The direct per-procedure cost is €2,246.31 for a Da Vinci procedure and €1995 for a Hugo RALP. In the local setting, Hugo RAS provides 11% of cost saving for RALP. By applying this per-procedure cost to our clinical data, the expenditure for the entire index hospitalization is € 6.7755,1 for Da Vinci and € 6.637,15 for Hugo RALP. The new Hugo RAS system is willing to reduce direct expenditures of robotic surgery for RALP; furthermore, it provides similar peri-operative outcomes compared to the Da Vinci. However, other drivers of costs should be taken into account, such as the duration of OR use-that is more than just console time and may depend on the facility's background and organization. Further variations in direct costs of robotic systems are related to caseload, local agreements and negotiations. Thus, cost comparison of new robotic platform still remains an ongoing issue.
Identifiants
pubmed: 38869636
doi: 10.1007/s11701-024-01930-w
pii: 10.1007/s11701-024-01930-w
doi:
Types de publication
Journal Article
Comparative Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
251Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.
Références
Sadri H, Fung-Kee-Fung M, Shayegan B, Garneau PY, Pezeshki P (2023) A systematic review of full economic evaluations of robotic-assisted surgery in thoracic and abdominopelvic procedures. J Robot Surg. https://doi.org/10.1007/s11701-023-01731-7
doi: 10.1007/s11701-023-01731-7
pubmed: 37843673
pmcid: 10678817
Bravi CA, Paciotti M, Balestrazzi E, Piro A, Piramide F, Peraire M, Sarchi L, Mottaran A, Nocera L, De Backer P, De Naeyer G, D’Hondt F, De Groote R, Mottrie A (2023) Outcomes of robot-assisted radical prostatectomy with the hugo RAS surgical system: initial experience at a high-volume robotic center. Eur Urol Focus 9(4):642–644. https://doi.org/10.1016/j.euf.2023.01.008
doi: 10.1016/j.euf.2023.01.008
pubmed: 36690548
Ragavan N, Bharathkumar S, Chirravur P, Sankaran S (2023) Robot-assisted laparoscopic radical prostatectomy utilizing Hugo RAS platform: initial experience. J Endourol 37:147–150
doi: 10.1089/end.2022.0461
pubmed: 36205571
Bravi CA, Balestrazzi E, De Loof M, Rebuffo S, Piramide F, Mottaran A, Paciotti M, Sorce G, Nocera L, Sarchi L, Peraire M, Colla’-Ruvolo C, Frego N, Piro A, Ticonosco M, De Backer P, Farinha R, Van Den Bossche H, De Naeyer G, D’Hondt F, De Groote R, Mottrie A (2023) Robot-assisted radical prostatectomy performed with different robotic platforms: first comparative evidence between da vinci and hugo robot-assisted surgery robots. Eur Urol Focus. https://doi.org/10.1016/j.euf.2023.08.001
doi: 10.1016/j.euf.2023.08.001
pubmed: 37634969
Ploussard G, Grabia A, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Lequeu CE; CC-AFU, Cancerology Committee of the Association Française d’Urologie (2022) Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic). World J Urol. https://doi.org/10.1007/s00345-021-03878-0
doi: 10.1007/s00345-021-03878-0
Salkowski M, Checcucci E, Chow AK, Rogers CC, Adbollah F, Liatsikos E, Dasgupta P, Guimaraes GC, Rassweiler J, Mottrie A, Breda A, Crivellaro S, Kaouk J, Porpiglia F, Autorino R (2023) New multiport robotic surgical systems: a comprehensive literature review of clinical outcomes in urology. Ther Adv Urol. https://doi.org/10.1177/17562872231177781
doi: 10.1177/17562872231177781
pubmed: 37325289
pmcid: 10265325
Okhawere KE, Shih IF, Lee SH, Li Y, Wong JA, Badani KK (2021) Comparison of 1 year health care costs and use associated with open vs robotic-assisted radical prostatectomy. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2021.2265
doi: 10.1001/jamanetworkopen.2021.2265
pubmed: 33749767
pmcid: 7985723
Sighinolfi MC, Sarchi L, Gaia G, Formisano G, Turri F, Sangalli M, Calcagnile T, Assumma S, Panio E, Darisi R, Afonina M, Grasso A, Dell’Orto P, Piacentini I, Salay A, Barabino M, Pisani A, Terzoni S, Marconi A, Bianchi PP, Rocco B (2023) Multimodular robotic systems (Hugo RAS and Versius CMR) for pelvic surgery: tasks and perspectives from the bed-side assistant. J Robot Surg 17(6):3039–3043. https://doi.org/10.1007/s11701-023-01718-4
doi: 10.1007/s11701-023-01718-4
pubmed: 37775674
Dixon S, Hill H, Flight L, Khetrapal P, Ambler G, Williams NR, Brew-Graves C, Kelly JD, Catto JWF, iROC Study Team (2023) Cost-Effectiveness of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy for Patients With Bladder Cancer. JAMA Netw Open 6(6):e2317255
doi: 10.1001/jamanetworkopen.2023.17255
pubmed: 37389878
pmcid: 10314306
Sighinolfi MC, Terzoni S, Scanferla E, Bianchi PP, Formisano G, Piccolo G, Barabino M, Pisani A, Salaj A, Gaia G, Marconi AM, Turri F, Sangalli M, Centanni S, Stocco M, Chiumello D, Assumma S, Sarchi L, Calcagnile T, Panio E, Grasso A, Dell’Orto P, Mariani NM, Verrusio C, Baisi A, Bozzini G, Rocco B (2023) Prior robotic console expertise may improve basic skills at the new hugo ras simulator: results from a cohort trial and implications for skill transference across platforms. Eur Urol Open Sci. https://doi.org/10.1016/j.euros.2023.04.008
doi: 10.1016/j.euros.2023.04.008
pubmed: 37441345
pmcid: 10334229